Technical Expertise in Artificial Intelligence

The Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), Division of Bioinformatics and Biostatistics (DBB) requires Technical Expertise in Artificial Intelligence; an experienced individual with written and oral presentation skills, a thorough understanding of bioinformatics with specific knowledge in Artificial Intelligence (AI) in the area of reproducibility, interpretability and transparency. One of the essential roles of the Division of Bioinformatics and Biostatistics (DBB) at the National Center for Toxicological Research (NCTR) is to deal with the rapid growth of biomedical data present in the public domain and generated within the Food and Drug Administration (FDA), and develop state-of-art bioinformatics and biostatistics methodologies to translate these massive data to knowledge to be used in the FDA. One area of this research is artificial intelligence (AI). Specifically, the goal is to evaluate, develop and employ the AI methodologies with a specific emphasis on its reproducibility, transparency and interpretability. This will aid in the efforts in the FDA to (1) develop the policy in regulation for the products that contains AI and (2) improve the agency’s operation by incorporating AI methods in regulatory science.